http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060088906-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99a99e4efe6f4ba041be7b6b9bc0cd68 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate | 1998-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f273adc7d8150eda7904e3fc5b75126 |
| publicationDate | 2006-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20060088906-A |
| titleOfInvention | Improved formulations for local non-invasive use in vivo |
| abstract | Even if the average diameter of the pores is smaller than the average diameter of the penetrant, the adaptability of the penetrant allows the penetrant to carry the drug after the penetrant enters the void or to allow the drug to penetrate the pores. A formulation consisting of a molecular sequence that can pass through, wherein the viscosity of the formulation is increased from above the viscosity of the non-enriched formulation to a maximum of 5 Nm / s so that at least one viscosity modifier and an oxidation index can be expanded and maintained. At least one antioxidant in an amount capable of reducing the increase to less than 100% per 6 months and the number of bacteria per total mass (g) of the total formulation after 4 days, from 1 million to less than 100 for aerobic bacteria, Contains bactericides that can be reduced to less than 10 for bacteria and less than 1 for Pseudomonas aeruginosa or Staphylococcus aureus Formulation which comprises. |
| priorityDate | 2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 689.